17 Nov 2025

MSI to Acquire 18 Percent Stake in Barings for $1.44 Billion

"Cravath represented Mitsui Sumitomo Insurance Co., Ltd. (MSI) in its agreement to acquire an 18% equity interest in Barings LLC from Massachusetts Mutual Life Insurance Company (MassMutual) for approximately $1.44 billion; Barings will remain an independent MassMutual subsidiary."

Cravath represented Mitsui Sumitomo Insurance Co., Ltd. (MSI) in the transaction. On November 17, 2025, MSI agreed to acquire an 18% equity interest in Barings LLC, an asset management company and wholly owned subsidiary of Massachusetts Mutual Life Insurance Company (MassMutual), from MassMutual. MassMutual will receive approximately $1.44 billion as a result of the transaction. Barings will continue to operate as an independent subsidiary of MassMutual following the sale. Cravath represented MSI with a team composed by: partner G.J. Ligelis Jr. (lead) and of counsel Nathan Noh, associates Connor F. O’Neill and Thomas F. Newcomb and foreign associate Guglielmo Ziani on M&A matters; partner Christopher K. Fargo and associates Carlos Nicholas Obando and Chloe Amarilla on tax matters; partner Amanda Hines Gold and associate Caroline Wyatt on executive compensation and benefits matters; partner David J. Kappos and associates Liza C. Clark and Albert Wong on intellectual property matters; partner Jeffrey T. Dinwoodie and associate Max D. Brashear on financial institutions matters; practice area attorney Brian M. Budnick on real estate matters; and Jason Yung Liang on intellectual property matters.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.